Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes
In this study, the interactions of five silymarin components (silybin A, silybin B, isosilybin A, silychristin, and 2,3-dehydrosilychristin) and their sulfate metabolites were examined with human serum albumin and CYP (2C9, 2C19, 2D6, and 3A4) enzymes. Our results demonstrate that each compound tested forms stable complexes with albumin, and certain silymarin components/metabolites can inhibit CYP enzymes. Most of the sulfate conjugates were less potent inhibitors of CYP enzymes, but 2,3-dehydrosilychristin-19-O-sulfate showed the strongest inhibitory effect on CYP3A4. Based on these observations, the simultaneous administration of high dose silymarin with medications should be carefully considered, because milk thistle flavonolignans and/or their sulfate metabolites may interfere with drug therapy.PMID:33706132 | DOI:10.1016/j.biopha.2021.111459
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Zelma Faisal Violetta Mohos Eszter Flisz ár-Nyúl Kate řina Valentová Krist ýna Káňová Be áta Lemli S ándor Kunsági-Máté Mikl ós Poór Source Type: research
More News: Complementary Medicine | Diets | Drugs & Pharmacology | Fruit | Liver | Milk | Milk Thistle | Nutrition | Study | Urology & Nephrology